Potential changes to MRLs under EC Regulation 396/2005
Since September 2008 all statutory MRLs have been set on an EC-wide basis under Regulation 396/2005. Proposals to set, modify or delete MRLs in Regulation 396/2005 are under regular consideration. These proposals are based on EFSA Opinions and are subject to votes in the EU Standing Committee on the Food Chain and Animal Health (Residues section). Proposals for lowered MRLs are notified to the World Trade Organisation (WTO) following the first indicative vote to allow third countries to raise any points of difficulty. Once all concerns have been addressed a formal vote is taken by the Committee, after which the proposal is adopted provided the necessary majority of member states is secured and following scrutiny by the European Parliament and Council.
We welcome any comments on these proposals. If possible, please submit these well in advance of discussions in the Standing Committee to Russell Wedgbury (russell.wedgbury@hse.gsi.gov.uk ).
The next Standing Committee meeting is scheduled for 13 & 14 June 2013.
| Actives | Possible applicable date | SANCO Proposal/Draft Regulation | Further details |
| bifenazate
chlorpropham
esfenvalerate
fludioxonil
thiobencarb | To be discussed at June 2013 Standing Committee. Further details to be provided following the June meeting. | Sanco 10698/2013 Annex. | Proposal includes MRLs reviewed under Article 12 of Regulation 396/2005. Enters into force 20 days following publication in the Official Journal and shall apply 6 months later. |
| bitertanol
chlorfenvinphos
dodine
vinclozolin | To be discussed at June 2013 Standing Committee. Further details to be provided following the June meeting. | Sanco 10094/2013 Annex. | Proposal amends MRLs following revocation of uses and the identification of some safety concerns. Enters into force 20 days following publication in the Official Journal. |
| 2,4-D
beflubetamid
cyclanilide
diniconazole
fipronil
florasulam
milbemectin
S-metolachlor | To be discussed at June 2013 Standing Committee. Further details to be provided following the June meeting. | Sanco 11264/2012 Annex. | Proposal includes MRLs reviewed under Article 12 of Regulation 396/2005. Enters into force 20 days following publication in the Official Journal and shall apply 6 months later. |
| cyromazine
fenpropidin
formetanate
oxamyl
tebuconazole | To be discussed at June 2013 Standing Committee. Further details to be provided following the June meeting. | Sanco 12783/2011 Annex. | Proposal includes active substances with expired essential uses. MRLs are reduced to LOD unless substantive levels needed based on Codex levels or import tolerances. Enters into force 20 days following publication in the Official Journal and shall apply 6 months later. |
| acequinocyl
bixafen
diazinon
difenoconazole
etoxazole
fenhexamid
fludioxonil
isopyrazam
lambda-cyhalothrin
profenofos
prothioconazole | Publication of amending Regulation likely in August/ September 2013 Awaiting publication following European Parliament and Council scrutiny. | Sanco 10586/2013 Annex. | Proposal voted through at April 2013 Standing Committee. Voted proposal includes MRLs to address new and changed uses and the implementation of Codex levels. Enters into force one day following publication in the Official Journal. |
| diphenylamine | Publication of amending Regulation likely in August/ September 2013 Awaiting publication following European Parliament and Council scrutiny. | Sanco 12334/2012 Annex IIIA. | Proposal voted through at April 2013 Standing Committee. Voted proposal includes MRLs reviewed under Article 12 of Regulation 396/2005. Enters into force 20 days following publication in the Official Journal and shall apply 6 months later. |
| acetamiprid
adoxophyes orana GV strain BV-0001
azoxystrobin
clothianidin
fenpyrazamine
heptamaloxyloglucan
metrafenone
paecilomyces lilacinus strain 251
propiconazole
quizalofop-P
spiromesifen
tebuconazole
thiamethoxam
zucchini yellow mosaik virus weak strain | Publication of amending Regulation likely in June/July 2013 Awaiting publication following European Parliament and Council scrutiny. | Sanco 10065/2013 Annex. | Proposal voted through at February 2013 Standing Committee. Voted proposal includes MRLs to address new and changed uses and the implementation of Codex levels. Enters into force one day following publication in the Official Journal. |
| 2,4 DB
dimethomorph
indoxacarb
pyraclostrobin | Publication of amending Regulation likely in June/July 2013 Awaiting publication following European Parliament and Council scrutiny. | Sanco 10392/2012 Annex II (part 1) Annex II (part 2) | Proposal voted through at February 2013 Standing Committee. Voted proposal includes MRLs reviewed under Article 12 of Regulation 396/2005. Enters into force 20 days following publication in the Official Journal and shall apply 6 months later. |
| clodinafop
clomazone
diuron
ethalfluralin
ioxynil
iprovalicarb
maleic hydrazide
mepanipyrim
metconazole
prosulfocarb
tepraloxydim | Publication of amending Regulation likely in June/July 2013 Awaiting publication following European Parliament and Council scrutiny. | Sanco 10376/2012 Annex II Annex V | Proposal voted through at February 2013 Standing Committee. Voted proposal includes MRLs reviewed under Article 12 of Regulation 396/2005. Enters into force 20 days following publication in the Official Journal and shall apply 6 months later. |
Contact: Russell Wedgbury; tel 01904 455780; fax 01904 455733; e-mail russell.wedgbury@hse.gsi.gov.uk
A list of published Commission Regulations is available on our Published Regulations page.
[back to top]
